ImmunityBio (IBRX) Other Working Capital Changes (2014 - 2026)
ImmunityBio (IBRX) reported Other Working Capital Changes of $16000.0 for Q1 2026, down 93.42% year-over-year from $243000.0 in Q1 2025, and down 80.49% quarter-over-quarter from $82000.0 in Q4 2025.
ImmunityBio (IBRX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Other Working Capital Changes data on file, last reported at $16000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $16000.0, down 93.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $376000.0 (up 35.25% YoY), and the FY2025 annual result was $570000.0, up 422.94% from the prior year.
- Other Working Capital Changes eased to $16000.0 in Q1 2026 per IBRX's latest filing, from $82000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $14.3 million in Q2 2022 and troughed at -$14.2 million in Q4 2022.
- A 5-year average of $264470.6 and a median of $74000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 1313.64% in 2022, then jumped 11328.57% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$14.2 million in 2022, then surged by 101.42% to $201000.0 in 2023, then tumbled by 118.41% to -$37000.0 in 2024, then soared by 321.62% to $82000.0 in 2025, then plunged by 80.49% to $16000.0 in 2026.
- Business Quant data shows IBRX's Other Working Capital Changes at $16000.0 in Q1 2026, $82000.0 in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 243,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Dec 31, 2023 | 201,000.00 |